NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD

1.21

-0.05 (-3.97%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	1.26
Open	1.27
Bid	1.10 x 3000
Ask	1.39 x 20000
Day's Range	1.21 - 1.38
52 Week Range	0.12 - 7.80
Volume	609,273
Avg. Volume	3,081,046

Market Cap	7.092M
Beta	3.77
PE Ratio (TTM)	N/A
EPS (TTM)	-34.98
Earnings Date	Mar 28, 2018 - Apr 2, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	3.00

Trade prices are not sourced from all markets

All

News

Press Releases

GlobeNewswire23 hours ago
InspireMDs CGuard Embolic Prevention System to be Featured at ICCA Stroke 2018 in Warsaw, Poland
TEL AVIV, ISRAEL, April 19, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
GlobeNewswire17 days ago
InspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 Million
TEL AVIV, Israel, April 03, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced preliminary unaudited sales results ...
ACCESSWIRE22 days ago
Blog Exposure - InspireMD Announced Regulatory Approval for CGuard Embolic Prevention System and MGuard Prime in Peru
Stock Monitor: Avinger Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 29, 2018 / Active-Investors.com has just released a free research report on InspireMD, Inc. (NYSE: NSPR ). If you want access ...
GlobeNewswire23 days ago
InspireMD, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock
Tel Aviv, Israel, March 28, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced the pricing of an underwritten public ...
GlobeNewswire24 days ago
InspireMD, Inc. Announces Proposed Public Offering of Common Stock
Tel Aviv, Israel, March 27, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that it intends to offer and sell, ...
GlobeNewswire24 days ago
InspireMD Receives Regulatory Approval for both CGuard™ EPS and MGuard Prime™ in Peru
Tel Aviv, Israel, March 27, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that it has received regulatory approval ...
Simply Wall St.last month
With A -53.98% Earnings Drop, Is InspireMD Inc’s (NYSEMKT:NSPR) Performance A Concern?
When InspireMD Inc (AMEX:NSPR) released its most recent earnings update (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of its industryRead More...
GlobeNewswire2 months ago
InspireMD Announces First Patient Treated with CGuard™ EPS in India
Patient with severe stenosis, calcification and thrombosis successfully treated with CGuard™ EPS. TEL AVIV, ISRAEL, March 05, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management ...
GlobeNewswire2 months ago
InspireMD Announces Expansion of its Distribution Network
Signs Exclusive Distributors for Greece and Caribbean Countries. Tel Aviv, Israel, March 01, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular ...
GlobeNewswire2 months ago
InspireMD, Inc. Announces Pricing of Public Offering of Common Stock
TEL AVIV, ISRAEL, Feb. 27, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced the pricing of an underwritten public ...
GlobeNewswire2 months ago
InspireMD, Inc. Announces Proposed Public Offering of Common Stock
Tel Aviv, Israel, Feb. 26, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that it intends to offer and sell, ...
ACCESSWIRE2 months ago
Today’s Research Reports on Trending Tickers: InspireMD and Eli Lilly and Company
NEW YORK, NY / ACCESSWIRE / February 23, 2018 / U.S. equities recovered on Thursday with the Dow Jones and S&P 500 closing in the green. The Federal Reserve released minutes from their Wednesday meeting ...
GlobeNewswire2 months ago
InspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea
Solvit Medical to fund all regulatory, registration and reimbursement submissions. TEL AVIV, ISRAEL, Feb. 22, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies ...
GlobeNewswire2 months ago
InspireMD Announces Commercial Launch and First Sales of CGuard™ EPS in India
TEL AVIV, ISRAEL, Feb. 20, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced the commercial launch and first sales ...
GlobeNewswire2 months ago
InspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard™ EPS Fourth Quarter Sales Increase 211% Versus Same Period Last year
TEL AVIV, Israel, Feb. 14, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced results for the fourth quarter and ...
ACCESSWIRE2 months ago
Today’s Research Reports on Trending Tickers: Eli Lilly and Company and InspireMD
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / On Wednesday, U.S. markets failed to continue on Tuesday's gains as investors worried about rising bond yields and interest rates. The Dow Jones Industrial ...
GlobeNewswire2 months ago
InspireMD Announces 1-for-35 Reverse Stock Split
Tel Aviv, Israel, Feb. 07, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced a 1- for-35 reverse split of its common ...
ACCESSWIRE3 months ago
InspireMD, CGuard is Ramping up Revenues, Business Outlook, and Analysts Review
NEW YORK, NY / ACCESSWIRE / February 1, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
GlobeNewswire3 months ago
InspireMD's CGuard Embolic Prevention System Featured in a Second Live Case Transmission at LINC 2018 by Leading Interventional Cardiologists
TEL AVIV, ISRAEL, Jan. 31, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
GlobeNewswire3 months ago
InspireMD’s CGuard™ Embolic Prevention System Featured in Successful Live Case Transmissions at LINC 2018 by Leading Vascular Surgeons
TEL AVIV, ISRAEL, Jan. 30, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
GlobeNewswire3 months ago
InspireMD’s CGuard Embolic Prevention System to be Prominently Featured in Two Live Case Transmissions at LINC 2018
TEL AVIV, ISRAEL, Jan. 26, 2018-- InspireMD, Inc., a leader in embolic prevention systems/ thrombus management technologies and neurovascular devices, today announced that its CGuard™ Embolic Prevention ...
ACCESSWIRE3 months ago
Today’s Research Reports on Trending Tickers: Akers Biosciences and InspireMD, Inc.
NEW YORK, NY / ACCESSWIRE / January 10, 2018 / U.S. markets continued to climb to new record highs as we enter into earnings season. Major financial companies, BlackRock, J.P. Morgan Chase and Wells Fargo, ...